Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19

Blood. 2020 Aug 6;136(6):766-768. doi: 10.1182/blood.2020006695.

Abstract

Berzuini et al report the observation that nearly half of patients with COVID-19 tested at their blood center had a positive direct antiglobulin test (DAT). However, eluates did not react with any test cells but did react with red cells from other patients with COVID-19 that were DAT negative. This suggests that COVID-19 may modulate the red cell membrane and present novel antigenic epitopes.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anemia / complications
  • Anemia / immunology
  • Anemia / therapy
  • Autoantibodies / analysis
  • Autoantibodies / immunology
  • Betacoronavirus / immunology
  • Betacoronavirus / isolation & purification
  • Blood Transfusion
  • COVID-19
  • Coombs Test
  • Coronavirus Infections / complications
  • Coronavirus Infections / immunology
  • Coronavirus Infections / therapy*
  • Erythrocytes / immunology*
  • Female
  • Humans
  • Immunoglobulin G / analysis
  • Immunoglobulin G / immunology*
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / therapy*
  • SARS-CoV-2

Substances

  • Autoantibodies
  • Immunoglobulin G